Chiron Ventures

Chiron Ventures is a Beijing-based investment firm established in 2008 that specializes in the healthcare sector. The firm focuses on innovation and investment in medical health, leveraging its extensive experience and resources in medical technology development and entrepreneurship. Chiron Ventures provides significant support and professional services to its investment projects, aiming to advance medical innovation and market development. Through its targeted approach, the firm seeks to contribute to the growth of the healthcare industry by backing promising ventures that enhance medical solutions and technologies.

David Liu

Founder and Chairman

Wang Zhiyong

Director

10 past transactions

HiciCare

Series A in 2023
HiciCare is a medical technology company that specializes in developing interventional medical devices designed for treating special and complex lesions. The company focuses on creating minimally invasive solutions that leverage advanced technologies such as medical optical sensing and ultrafast laser systems. By emphasizing precise control of medical energy, HiciCare aims to deliver innovative devices that enhance treatment options for healthcare providers and improve patient outcomes.

Ren Labs

Seed Round in 2022
Ren Labs is a multichain technology promoting the research and development of initiatives to expand the Ren ecosystem and the broader blockchain space.

Pulnovo Medical

Venture Round in 2021
Pulnovo Medical, founded in 2013 in Wuxi, Anhui, specializes in the development, production, and service of innovative medical devices aimed at treating pulmonary hypertension. The company focuses on advanced pulse radiofrequency ablation technology, which includes pioneering high-frequency ablation equipment and intravascular catheters. These products are designed to enhance the quality of life for patients suffering from pulmonary hypertension and heart failure, offering a novel approach to treatment with a commitment to improving patient outcomes. Pulnovo Medical holds global invention patents for its unique technologies, underscoring its role as a leader in this specialized medical field.

Green Growth Brands

Post in 2019
Green Growth Brands is a consumer products company focused on health, wellness, and lifestyle, founded in 2018 and headquartered in Ohio. The company operates in the cannabis sector, engaging in the cultivation, production, distribution, and retail sale of cannabis products globally. It also produces and sells CBD-infused personal care products through various channels, including retail, digital, and wholesale. Green Growth Brands encompasses a diverse range of brands, including CAMP and Meri + Jayne, and collaborates with a team of retailers, scientists, botanists, and business leaders to support its mission.

Chinagene Tech

Corporate Round in 2019
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Wanxu Software

Series A in 2018
Wanxu Software is a healthcare company.

Aining Care Service

Series A in 2018
Aining Care Service is a nursing care. They provide convenient home care, rehabilitation, and life care services for the disabled, sick, disabled, postoperative people, and the elderly by introducing advanced foreign technologies and concepts.

LungCare

Series A in 2015
LungCare is a company focused on developing advanced technologies for the diagnosis of lung cancer. Its product offerings include a 3D CT scanner equipped with electromagnetic positioning and various bronchoscopes. These innovations aim to enhance the accuracy and reliability of lung cancer diagnosis, providing healthcare professionals with improved tools to detect the disease in patients more effectively.

Pulnovo Medical

Seed Round in 2013
Pulnovo Medical, founded in 2013 in Wuxi, Anhui, specializes in the development, production, and service of innovative medical devices aimed at treating pulmonary hypertension. The company focuses on advanced pulse radiofrequency ablation technology, which includes pioneering high-frequency ablation equipment and intravascular catheters. These products are designed to enhance the quality of life for patients suffering from pulmonary hypertension and heart failure, offering a novel approach to treatment with a commitment to improving patient outcomes. Pulnovo Medical holds global invention patents for its unique technologies, underscoring its role as a leader in this specialized medical field.

Sino-US Telemed

Angel Round in 2011
Sino-US Telemed is a provider of advanced clinical imaging services, specializing in the transmission, storage, and sharing of medical images. The company offers a range of services, including 3D reconstruction, surgery planning, diagnosis, and disease screening. In addition to clinical services, Sino-US Telemed focuses on cooperative education and training for radiology physicians, enhancing their skills in medical imaging. By leveraging technological and business innovations, the platform aims to deliver high-quality precision medicine, ultimately helping patients safeguard their health and well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.